The project aims to define the key cellular, molecular and structural alterations in the bone marrow in pre-malignant conditions. We will focus on targetable interactions between pre-malignant cells and their spatial tumor microenvironment(s) to bypass malignant transformation, while enhancing healthy tissue function. Our goal is to leverage those findings towards designing and functional validation of novel therapeutic intervention strategies for longer disease-free survival against hematologic conditions that often leading to acute myeloid leukemia (i.e. clonal hematopoiesis).